Skip to content

Survodutide vendor rankings, purity, and price

Independent lab results for Survodutide, updated daily. No vendor can pay to rank higher.

Survodutide reconstitution calculator

Phase 3

Vendors carrying it

11

Median purity

99.8%

Price range

$2.75–$3.50/mg

Newest test

Sep 27, 2026

ShareShare on XRedditFacebook

Survodutide vendors ranked by PVS

PVS is a 0–100 score from lab results, published COAs, and community reports — How we score it.

Best evidence + price: Bulk Peptide Supply — Highest PVS with a listed price, at least one lab result, and no price flag.

Filter Survodutide vendors
#VendorPVSPurityPrice
1Umbrella Labs1 independent94 Exceptional99.8%Price not listed
2Bulk Peptide Supply1 independent91 Exceptional99.8%$3.13/mg
3Modern Aminos1 independent89 Strong99.7%Price not listed
4Peptide Supply2 independent87 Strong99.7%Price not listed
5Peptidology1 independent81 Strong99.8%Price not listed
6Polaris PeptidesNo independent results69 Below averageNo purity on filePrice not listed
7UtherNo independent results68 Below averageNo purity on filePrice not listed
8Loti Labs1 independent63 Below average99.8%Price not listed
9Paramount PeptidesNo independent results58 PoorNo purity on filePrice not listed
10Peptide-SNo independent results58 PoorNo purity on filePrice not listed
11Skye PeptidesNo independent results53 PoorNo purity on filePrice not listed

Ranked by PVS, which no payment can change. Purity is the median of lab results for this compound. Vendor self-published PDFs don't count.

Mixing calculator

Math helper for lab reconstitution. Not dosing advice.

Vial amount
—mg/mL concentration
—mcg per 0.1 mL
—U-100 units

Enter a vial amount and water volume to see concentration.

Example only. 10 mg in 2 mL is 5 mg/mL (500 mcg per 0.1 mL). A 100 mcg target amount is 2 units on a U-100 syringe.

Survodutide price per mg

Vials and injectables

Min $2.75/mgMedian $3.13/mgMax $3.50/mg

Median is $3.13/mg. Vendors under half the median ($1.56/mg) with no COA in the last 12 months are flagged.

Source: Vendor storefronts. As of Nov 14, 2026 (newest storefront check).

Listed storefront price after any permanent public discount code. Listed price is not the price you will pay at checkout. No affiliate codes, no referral fees. See full price methodology

Survodutide lab results

Research evidence for Survodutide

Phase 3

High Human Evidence (Phase 3) for Survodutide. peptides.farm indexes 3 human studies, 2 animal studies, and 4 primary citations. Regulatory tier: In Clinical Trials.

Human studies

3

Animal studies

2

Citations

4

COA chemistry benchmarks

Theoretical salt and content figures for Survodutide. Compare them to the acetate, TFA, and net peptide content on a certificate of analysis. These are reference benchmarks, not a result for any vendor batch.

CAS
2309168-82-9
Free-base MW
4231.69 Da
Basic sites
3
Theoretical acetate
5.33%
Theoretical TFA
11.13%
Net peptide content
90.5%

Public reference from peptides.farm (Datil Technologies). Theoretical COA benchmarks for comparing a certificate of analysis. Not a measured vendor result and not dosing guidance. Source monograph.

What to look for in Survodutide

Have a COA for Survodutide? Check it against the lab results on file.

About Survodutide

Survodutide is an investigational dual agonist peptide that activates both GLP-1 and glucagon receptors. It is under clinical investigation by Boehringer Ingelheim and Zealand Pharma for metabolic and hepatic research endpoints.

Also sold as: BI 456906

Molecular weight
4857.6 g/mol
Half-life
~6-7 days (subcutaneous)
Sequence
Modified 29-amino acid peptide (GLP-1/glucagon dual agonist)

For research purposes only. PepAssure publishes vendor verification data and does not endorse any use.

Some lab results sourced from Peptigrity, peptigrity.com (CC BY 4.0).

Prices sourced from vendor storefronts, scraped by PepAssure.

Last updated Nov 16, 2026 by the nightly scoring run. Methodology · Verify a COA